We comply with the
HONcode standard for trustworthy health information:
verify here

The European LeukemiaNet is an EU-funded organisation of physicians, scientists and patients with interest in leukemia. It aims to improve the treatment and knowledge about Leukemia in Europe and spread excellence. The website delivers information for physicians, patients (e.g. patient organisations in Europe), ongoing clinical trials and further information about the disease. You can get information about the European LeukemiaNet in various european languages. The European LeukemiaNet is funded by the 6th Framework Program of the European Community.

News

Update on ELN recommendations

The most visible results of the ELN are the guidelines and management recommendations for virtually every leukemia and interdisciplinary speciality which have lain the groundwork for uniform definitions and standards required for common clinical trials and projects.

Regulation on clinical trials - Comments and points of interest for academic clinical trials

In July 2012, the European Commission prepared a proposal for the European Parliament, which is not a directive but a regulation. Couching the legislation as a regulation rather than a directive will ensure that the new rules, once finalized and adopted, will have an immediate and binding impact across the EU, avoiding ...

ARCADE

New trial: A Multicenter, Randomised, Double-blind, Placebo-controlled Study of Darbepoetin Alfa for the Treatment of Anaemic Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

9th Information Letter

The 9th Information Letter is available online. For the first time, this issue contains summaries of the most important clinical results from oral presentations of the 54th ASH Annual Meeting which were selected and summarized by ELN experts.

CML patient information

The Czech Leukemia Study Group for Life (CELL) plublished a Czech information for CML-patients and their relatives.

European Medicines Agency releases a public database of suspected adverse drug reaction reports

In May 2012 the European Medicines Agency launched the new website www.adrreports.eu publishing suspected side-effect reports of drugs authorised in the European Economic Area. The website for the general public is available in all official European languages.

Events
Fr 2013/05/24 - Su 2013/05/26 ESH-EHA Tutorial on Lymphomas FOCUS ON LYMPHOMA AND OTHER HEMATOLOGICAL CONSEQUENCES OF RETROVIRAL INFECTION
Fr 2013/05/31 - Tu 2013/06/04 ASCO Annual Meeting Building Bridges to Conquer Cancer
Fr 2013/05/31 - Sa 2013/06/01 ESH Clinical Updates in Hematology on Acute Myeloid Leukemia / Myelodysplastic Syndromes
Th 2013/06/13 - Su 2013/06/16 18th Congress of EHA
Fr 2013/06/28 - Sa 2013/06/29 22. International CML-Workshop

The European LeukemiaNet

189 Participating Centers in 38 Countries (1000 Researchers and Associates) are cooperating in the European Leukemia Net. The objective is to integrate the 108 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 105 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia related research and health care (data updated March 2012).

Keywords: leukemia, leukaemia, leukämie, leucemie, leucémie, leucemia, leukemi, leukemie, lösemi, Лейкоз, λευχαιμία, سرطان الدّم, 白血病, leukemija, leukemije, leŭkemio, biaŁacka,ש"עסרטן הדם, לויקמיה